Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ProMIS Neurosciences Inc.
Description mAb against CD38 disease specific epitopes (DSEs)
Molecular Target CD38
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationLeukemia
Indication DetailsTreat leukemia
Regulatory Designation
PartnerApexigen Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today